Physician profile
Erika Augustus
NPI 1447063128
$838.06
in general payments reported to CMS, 2019-2025
10 companies · $838 in 2025
The $838 reported for 2025 was more than what 77% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603 · Education: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.07 |
| Education | $234.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $308.45 | 2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $243.67 | 2025 | Xtandi |
| Endo USA, INC. | $121.18 | 2025 | Xiaflex, Aveed |
| Novartis Pharmaceuticals Corporation | $26.88 | 2025 | |
| Blue Earth Diagnostics | $25.35 | 2025 | Posluma |
| Teleflex LLC | $24.47 | 2025 | Barrigel |
| Accord Healthcare, INC. | $24.42 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.47 | 2025 | |
| Abbvie INC. | $20.73 | 2025 | |
| Tolmar, INC. | $19.44 | 2025 | Jatenzo, Eligard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Augustus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.